Stratec (ETR:SBS) Shares Up 2% – Here’s Why

Stratec SE (ETR:SBSGet Free Report) shares traded up 2% during mid-day trading on Monday . The stock traded as high as €25.45 ($27.66) and last traded at €25.45 ($27.66). 10,207 shares changed hands during trading, an increase of 63% from the average session volume of 6,253 shares. The stock had previously closed at €24.95 ($27.12).

Stratec Trading Up 2.0 %

The firm has a market cap of $305.75 million, a price-to-earnings ratio of 30.54, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16. The company’s 50-day moving average price is €30.69 and its 200-day moving average price is €33.16. The company has a quick ratio of 1.65, a current ratio of 2.52 and a debt-to-equity ratio of 66.97.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

See Also

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.